Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rubinstein

Showing results (261-270 of 308) with videos related to

Pageof 31
Sort By:
Oncoimmunology|January 4, 2018
Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancerDai Liu, Guangfu Li, Diego M Avella, et al.
Frontiers in Immunology|March 8, 2019
Fueling Cancer Immunotherapy With Common Gamma Chain CytokinesConnor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, et al.
Journal of the American College of Surgeons|February 25, 2012
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted hostMark P Rubinstein, Colleen A Cloud, Tracy E Garrett, et al.
The New England Journal of Medicine|November 26, 1998
Outcomes among 562 recipients of placental-blood transplants from unrelated donorsP Rubinstein, C Carrier, A Scaradavou, et al.
The New England Journal of Medicine|June 16, 2001
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donorsM J Laughlin, J Barker, B Bambach, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.
European Journal of Immunology|May 9, 2020
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8<sup>+</sup> T cellsConnor J Dwyer, Dimitrios C Arhontoulis, Guillermo O Rangel Rivera, et al.
Cancer Research|May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaWenxin Xu, Monica Jones, Bai Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2015
The inducible costimulator augments Tc17 cell responses to self and tumor tissueMichelle H Nelson, Sreenath Kundimi, Jacob S Bowers, et al.
Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Pageof 31

Showing results (261-270 of 308) with videos related to

Sort By:
Pageof 31
Oncoimmunology|January 4, 2018
Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancerDai Liu, Guangfu Li, Diego M Avella, et al.
Frontiers in Immunology|March 8, 2019
Fueling Cancer Immunotherapy With Common Gamma Chain CytokinesConnor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, et al.
Journal of the American College of Surgeons|February 25, 2012
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted hostMark P Rubinstein, Colleen A Cloud, Tracy E Garrett, et al.
The New England Journal of Medicine|November 26, 1998
Outcomes among 562 recipients of placental-blood transplants from unrelated donorsP Rubinstein, C Carrier, A Scaradavou, et al.
The New England Journal of Medicine|June 16, 2001
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donorsM J Laughlin, J Barker, B Bambach, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.
European Journal of Immunology|May 9, 2020
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8<sup>+</sup> T cellsConnor J Dwyer, Dimitrios C Arhontoulis, Guillermo O Rangel Rivera, et al.
Cancer Research|May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaWenxin Xu, Monica Jones, Bai Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2015
The inducible costimulator augments Tc17 cell responses to self and tumor tissueMichelle H Nelson, Sreenath Kundimi, Jacob S Bowers, et al.
Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Pageof 31